The Progressive Corporation (PGR) is one of the largest U.S. property and casualty insurers, best known for personal auto coverage sold through its direct, online, and independent-agency channels. After a mixed third-quarter 2026 report, shares trade near $219, leaving investors to weigh whether a climb toward the $242 mark is realistic. The following analysis examines the analyst price targets, fundamentals, and risks that frame that question.
The broader Street consensus is far from unanimous. S&P Global's compilation of 24 analysts points to an average one-year target near $230 and a "Hold" rating, with a low of $196 and a high of $266. Because that overall average is only about 5% above the current price, it fails a meaningful 10% upside test. I therefore focused on the individual, verifiable targets above the current quote.
Among the most recent revisions, UBS holds a Neutral rating at $238, Goldman Sachs keeps a Buy at $233, Roth MKM maintains a Buy at $245, Keefe Bruyette holds an Outperform at $246, Barclays carries an Overweight at $247, JPMorgan is Neutral at $250, and BofA's Joshua Shanker remains the most bullish with a Buy at $266. On the cautious side, Wells Fargo holds an Underweight at $196, while BMO Capital ($216), HSBC ($216), Morgan Stanley ($210), Freedom Capital Markets ($226), and Evercore ISI ($227) sit at or just above the current price. Averaging the nine targets above the share price produces the $242 central target.
The reasoning behind the spread is telling. Bulls cite Progressive's durable underwriting discipline, steady policy-in-force growth, and the potential for reserve releases and capital returns. Skeptics point to intense personal-auto competition, fading pricing momentum, and lower interest rates pressuring investment income.
At a latest verified price near $219, reaching $242 requires an advance of roughly 10%, a substantial but not extreme move for a large-cap insurer. The path would likely depend on sustained premium growth and stable underwriting margins rather than a sudden re-rating.
Progressive's third-quarter 2026 results were mixed. Net premiums written rose 4% to about $22.3 billion, and the combined ratio improved 80 basis points to 88.7%, signaling solid underwriting. However, GAAP EPS of $4.37 and revenue of about $23.2 billion came in modestly below consensus, and the stock slipped around 6% on the release. Book value per share of $59.51 was also down roughly 1.6% year over year, partly reflecting unrealized losses on fixed-maturity securities in a higher-rate environment.
Progressive trades within a 52-week range of roughly $189 to $239. The current quote near $219 sits in the upper-middle portion of that band. The $239-to-$240 area, near the 52-week high, represents a meaningful resistance level, while support has repeatedly formed in the $196-to-$210 zone. A push toward $242 would require clearing that prior-high resistance, a move not confirmed by the current structure.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms may use different frameworks. Investors should watch monthly results releases, notably the October figures due in mid-November, policy-in-force trends, combined-ratio performance, investment income, and any changes to buyback or dividend policy. Further analyst target revisions following the next earnings report and commentary on competitive pricing in personal auto will be important signals.
Traders tracking Progressive can complement fundamental research with AI Daily Buy/Sell Signals from Tickeron. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This helps traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening alone. Consider adding these AI-generated signals to your workflow for a more timely view of momentum and risk.
Can Progressive stock reach $242? The central target, derived from the nine analyst price targets above the current price, implies roughly a 10% gain — a meaningful but achievable threshold supported by strong policy growth and improving underwriting. The principal obstacles are slowing premium momentum, interest-rate pressure on investment income, and a recent earnings miss that rattled sentiment. With targets ranging from $196 to $266, analysts are clearly divided, and reaching $242 would require clearing the stock's prior-high resistance. The target should be read as an expectation derived from current analyst modeling, not a guarantee, and investors should watch monthly results and competitive pricing closely.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, PGR has been closely correlated with HIG. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if PGR jumps, then HIG could also see price increases.